|4Jul 25, 6:05 PM ET

Kirkov Kirko 4

4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Jul 25, 2025

Insider Transaction Report

Form 4
Period: 2025-07-10
Kirkov Kirko
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2025-07-10$0.59/sh+16,366$9,64016,366 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT